Related references
Note: Only part of the references are listed.Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms
A. Deshpande et al.
LEUKEMIA (2012)
Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
Sarah E. M. Herman et al.
BLOOD (2011)
Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
Ning Jin et al.
CLINICAL CANCER RESEARCH (2011)
Discovery of 5 Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway
Stephanos Ioannidis et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
A. Scuto et al.
LEUKEMIA (2011)
Lapatinib Induces Autophagy, Apoptosis and Megakaryocytic Differentiation in Chronic Myelogenous Leukemia K562 Cells
Huey-Lan Huang et al.
PLOS ONE (2011)
Global Phosphoproteomics Reveals Crosstalk Between Bcr-Abl and Negative Feedback Mechanisms Controlling Src Signaling
Liudmilla Rubbi et al.
SCIENCE SIGNALING (2011)
System-Wide Temporal Characterization of the Proteome and Phosphoproteome of Human Embryonic Stem Cell Differentiation
Kristoffer T. G. Rigbolt et al.
SCIENCE SIGNALING (2011)
Signal transduction by the atopy-associated human thymic stromal lymphopoietin (TSLP) receptor depends on Janus kinase function
Andreas Wohlmann et al.
BIOLOGICAL CHEMISTRY (2010)
Immunoglobulin heavy chain locus chromosomal translocations in B-cell precursor acute lymphoblastic leukemia: rare clinical curios or potent genetic drivers?
Martin J. S. Dyer et al.
BLOOD (2010)
Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group
Libi Hertzberg et al.
BLOOD (2010)
Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol
Gunnar Cario et al.
BLOOD (2010)
t(X;14)(p22;q32)/t(Y;14)(p11;q32) CRLF2-IGH translocations from human B-lineage ALLs involve CpG-type breaks at CRLF2, but CRLF2/P2RY8 intrachromosomal deletions do not
Albert G. Tsai et al.
BLOOD (2010)
Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia
Richard C. Harvey et al.
BLOOD (2010)
Site-directed mutagenesis reveals a unique requirement for tyrosine residues in IL-7Rα and TSLPR cytoplasmic domains in TSLP-dependent cell proliferation
Jun Zhong et al.
BMC IMMUNOLOGY (2010)
Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation
Ferenc A. Scheeren et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
Thymic Stromal Lymphopoietin Receptor-Mediated IL-6 and CC/CXC Chemokines Expression in Human Airway Smooth Muscle Cells: Role of MAPKs (ERK1/2, p38, and JNK) and STAT3 Pathways
Lianyu Shan et al.
JOURNAL OF IMMUNOLOGY (2010)
Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia
E. Chapiro et al.
LEUKEMIA (2010)
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
R. Eric Davis et al.
NATURE (2010)
Common variants at 5q22 associate with pediatric eosinophilic esophagitis
Marc E. Rothenberg et al.
NATURE GENETICS (2010)
PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium
Huaiyu Mi et al.
NUCLEIC ACIDS RESEARCH (2010)
Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia
Akinori Yoda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Thymic stromal lymphopoietin-mediated STAT5 phosphorylation via kinases JAK1 and JAK2 reveals a key difference from IL-7-induced signaling
Yrina Rochman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Distinct Signal Codes Generate Dendritic Cell Functional Plasticity
Kazuhiko Arima et al.
SCIENCE SIGNALING (2010)
NetPath: a public resource of curated signal transduction pathways
Kumaran Kandasamy et al.
GENOME BIOLOGY (2010)
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
Lisa J. Russell et al.
BLOOD (2009)
The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
Michael Hedvat et al.
CANCER CELL (2009)
Antitumor Efficacy of the Novel RAF Inhibitor GDC-0879 Is Predicted by BRAFV600E Mutational Status and Sustained Extracellular Signal-Regulated Kinase/Mitogen-Activated Protein Kinase Pathway Suppression
Klaus P. Hoeflich et al.
CANCER RESEARCH (2009)
Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
Fawn Qian et al.
CANCER RESEARCH (2009)
Kinases that control the cell cycle in response to DNA damage: Chk1, Chk2, and MK2
H. Christian Reinhardt et al.
CURRENT OPINION IN CELL BIOLOGY (2009)
TSLP Conditions the Lung Immune Environment for the Generation of Pathogenic Innate and Antigen-Specific Adaptive Immune Responses
Mark B. Headley et al.
JOURNAL OF IMMUNOLOGY (2009)
A New Approach for Quantitative Phosphoproteomic Dissection of Signaling Pathways Applied to T Cell Receptor Activation
Vinh Nguyen et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers
Peter Sabbatini et al.
MOLECULAR CANCER THERAPEUTICS (2009)
SGX523 is an exquisitely selective, ATP-competitive inhibitor of the MET receptor tyrosine kinase with antitumor activity in vivo
Sean G. Buchanan et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Identification of c-Src tyrosine kinase substrates in platelet-derived growth factor receptor signaling
Ramars Amanchy et al.
MOLECULAR ONCOLOGY (2009)
Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia
Charles G. Mullighan et al.
NATURE GENETICS (2009)
Thymic stromal lymphopoietin overproduced by keratinocytes in mouse skin aggravates experimental asthma
Zhikun Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
The tyrosine phosphatase Shp2 (PTPN11) in cancer
Gordon Chan et al.
CANCER AND METASTASIS REVIEWS (2008)
Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera
Gerlinde Werning et al.
CANCER CELL (2008)
Characterization of an Akt kinase inhibitor with potent pharmacodynamic and antitumor activity
Nelson Rhodes et al.
CANCER RESEARCH (2008)
The JAK kinase inhibitor CP-690,550 supresses the growth of human polycythemia vera cells carrying the JAK2V617F mutation
Taghi Manshouri et al.
CANCER SCIENCE (2008)
Small Molecule Recognition of c-Src via the lmatinib-Binding Conformation
Arvin C. Dar et al.
CHEMISTRY & BIOLOGY (2008)
Human TSLP directly enhances expansion of CD8(+) T cells
T. Akamatsu et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2008)
Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease
Sun Ying et al.
JOURNAL OF IMMUNOLOGY (2008)
The Role of Thymic Stromal Lymphopoietin in CD8+ T Cell Homeostasis
Yrina Rochman et al.
JOURNAL OF IMMUNOLOGY (2008)
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML
S. Park et al.
LEUKEMIA (2008)
Quantitative proteomics using stable isotope labeling with amino acids in cell culture
H. C. Harsha et al.
NATURE PROTOCOLS (2008)
Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS
Udayan Guha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Thymic stromal-derived lymphopoietin induces proliferation of pre-B leukemia and antagonizes mTOR inhibitors, suggesting a role for interleukin-7Rα signaling
Valerie I. Brown et al.
CANCER RESEARCH (2007)
Pharmacologic characterization of a potent inhibitor of class I phosphatidylinositide 3-kinases
Florence I. Raynaud et al.
CANCER RESEARCH (2007)
Cutting edge:: Direct action of thymic stromal lymphopoietin on activated human CD4+ T cells
Irina Rochman et al.
JOURNAL OF IMMUNOLOGY (2007)
Thymic stfomal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells
Zoulfia Allakhverdi et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Global proteomic profiling of phosphopeptides using electron transfer dissociation tandem mass spectrometry
Henrik Molina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Induction of IL-4 expression in CD4+ T cells by thymic stromal lymphopoietin
Miyuki Omori et al.
JOURNAL OF IMMUNOLOGY (2007)
TSLP: An epithelial cell cytokine that regulates T cell differentiation by conditioning dendritic cell maturation
Yong-Jun Liu et al.
ANNUAL REVIEW OF IMMUNOLOGY (2007)
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase
Zhengying Pan et al.
CHEMMEDCHEM (2007)
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells
Miriam Puttini et al.
CANCER RESEARCH (2006)
Functional and quantitative proteomics using SILAC
Matthias Mann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Global, in vivo, and site-specific phosphorylation dynamics in signaling networks
Jesper V. Olsen et al.
CELL (2006)
A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model
Hiroaki Ohno et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Phosphoproteomic analysis of Her2/neu signaling and inhibition
Ron Bose et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor
DH Albert et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC)
GA Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2006)
Gain-of-function/Noonan syndrome SHP-2/Ptpn11 mutants enhance calcium oscillations and impair NFAT signaling
P Uhlén et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
An iterative statistical approach to the identification of protein phosphorylation motifs from large-scale data sets
D Schwartz et al.
NATURE BIOTECHNOLOGY (2005)
Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice
BH Zhou et al.
NATURE IMMUNOLOGY (2005)
A role for TSLP in the development of inflammation in an asthma model
A Al-Shami et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin
J Yoo et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns
MR Larsen et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of TH2-attracting chemokines and disease severity
S Ying et al.
JOURNAL OF IMMUNOLOGY (2005)
Mechanism of divergent growth factor effects in mesenchymal stem cell differentiation
I Kratchmarova et al.
SCIENCE (2005)
In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants
T O'Hare et al.
CANCER RESEARCH (2005)
Potent and selective inhibitors of Akt kinases slow the progress of tumors in vivo
Y Luo et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway
A Gruhler et al.
MOLECULAR & CELLULAR PROTEOMICS (2005)
Characterization of AMN107, a selective inhibitor of native and mutant Bcr-Abl
E Weisberg et al.
CANCER CELL (2005)
Immunoaffinity profiling of tyrosine phosphorylation in cancer cells
J Rush et al.
NATURE BIOTECHNOLOGY (2005)
Negative regulation of HER2 signaling by the PEST-type protein-tyrosine phosphatase BDP1
M Gensler et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Inhibition of cell proliferation and cell cycle progression by specific inhibition of basal JNK activity - Evidence that mitotic Bcl-2 phosphorylation is JNK-independent
LH Du et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
A unique structure for epidermal growth factor receptor bound to GW572016 (Lapatinib): Relationships among protein conformation, inhibitor off-rate, and receptor activity in tumor cells
ER Wood et al.
CANCER RESEARCH (2004)
Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics
B Blagoev et al.
NATURE BIOTECHNOLOGY (2004)
Phosphopeptide-selective column-switching RP-HPLC with a titania precolumn
I Kuroda et al.
ANALYTICAL SCIENCES (2004)
Large-scale characterization of HeLa cell nuclear phosphoproteins
SA Beausoleil et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Phosphoproteomic analysis of the developing mouse brain
BA Ballif et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Antitumor activity of HKI-272, an orally active, irreversible inhibitor of the HER-2 tyrosine kinase
SK Rabindran et al.
CANCER RESEARCH (2004)
A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture
N Ibarrola et al.
ANALYTICAL CHEMISTRY (2003)
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor
PS Changelian et al.
SCIENCE (2003)
Structural basis for p38α MAP kinase quinazolinone and pyridol-pyrimidine inhibitor specificity
CE Fitzgerald et al.
NATURE STRUCTURAL BIOLOGY (2003)
The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling
BG Neel et al.
TRENDS IN BIOCHEMICAL SCIENCES (2003)
Stk10, a new member of the polo-like kinase kinase family highly expressed in hematopoietic tissue
SA Walter et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The role of C-terminal tyrosine phosphorylation in the regulation of SHP-1 explored via expressed protein ligation
ZS Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu
T Hideshima et al.
BLOOD (2003)
γ-secretase-mediated proteolysis in cell-surface-receptor signalling
ME Fortini
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies - Identification of a novel protein, Frigg, as a protein kinase A substrate
M Gronborg et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Critical role for Gab2 in transformation by BCR/ABL
M Sattler et al.
CANCER CELL (2002)
CT53518, a novel selective FLT3 antagonist for the treatment of acute myelogenous leukemia (AML)
LM Kelly et al.
CANCER CELL (2002)
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics
SE Ong et al.
MOLECULAR & CELLULAR PROTEOMICS (2002)
Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site
C Pargellis et al.
NATURE STRUCTURAL BIOLOGY (2002)
Closing in on the biological functions of FPS/FES and FER
P Greer
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae
SB Ficarro et al.
NATURE BIOTECHNOLOGY (2002)
SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase
BL Bennett et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Optimization of 4-phenylamino-3-quinolinecarbonitriles as potent inhibitors of Src kinase activity
DH Boschelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Cloning of human thymic stromal lymphopoietin (TSLP) and signaling mechanisms leading to proliferation
H Quentmeier et al.
LEUKEMIA (2001)
A novel family of phosphatidylinositol 4-kinases conserved from yeast to humans
B Barylko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
The SH2 domain containing tyrosine phosphatase-1 down-regulates activation of Lyn and Lyn-induced tyrosine phosphorylation of the CD19 receptor in B cells
AK Somani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Cloning of the murine thymic stromal lymphopoietin (TSLP) receptor: Formation of a functional heteromeric complex requires interleukin 7 receptor
LS Park et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
Cloning of a receptor subunit required for signaling by thymic stromal lymphopoietin
A Pandey et al.
NATURE IMMUNOLOGY (2000)
Analysis of receptor signaling pathways by mass spectrometry: Identification of Vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors
A Pandey et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
